- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ALI’s second-quarter revenues skyrocket
ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase
ALI Technologies, of Richmond, British Columbia, continues to reap the rewards of a healthy PACS market. The ultrasound miniPACS developer posted revenues of $3.1 million (Canadian) for the second quarter of fiscal 1997 (end-March 31), a 92% increase over the $1.6 million reported in the same period in 1996. Net income was $457,000 versus $6000 netted in the 1996 fiscal second quarter.
ALI celebrated several accomplishments in the second quarter, highlighted by the announcement that GE Medical Systems would purchase up to 19.9% of ALI's outstanding equity (SCAN 4/2/97). Negotiation over final documentation of the deal is ongoing, according to the company.
Other notable achievements in the second quarter included the first shipments of the UltraPACS 3.0 upgrade as well as the vendor's SWS 250 notebook PC-based sonographers' workstation. The company installed nine UltraPACS systems in the second quarter, seven of which were in North America.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
